Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 31;37(4):e440.
doi: 10.5001/omj.2022.22. eCollection 2022 Jul.

Prevalence of Methicillin-resistant Staphylococcus Aureus in India: A Systematic Review and Meta-analysis

Affiliations
Review

Prevalence of Methicillin-resistant Staphylococcus Aureus in India: A Systematic Review and Meta-analysis

Sharanagouda S Patil et al. Oman Med J. .

Abstract

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has increased and become a serious concern worldwide, including India. Additionally, MRSA isolates are showing resistance to other chemotherapeutic agents. Isolated and valuable reports on the prevalence of MRSA are available in India. There is no systematic review on the prevalence of MRSA in one place; hence, this study was planned. The overall prevalence of MRSA in humans in India was evaluated state-wise, zone-wise, and year-wise. A systematic search from PubMed, Indian journals, Google Scholar, and J-Gate Plus was carried out and retrieved 98 eligible articles published from 2015 to 2020 in India. The statistical analysis of data was conducted using R software. The overall prevalence of MRSA was 37% (95% CI: 32-41) from 2015 to 2019. The pooled prevalence of MRSA zone-wise was 41% (95% CI: 33-50), 43% (95% CI: 20-68), 33% (95% CI: 24-43), 34% (95% CI: 26-42), 36% (95% CI: 25-47), and 40% (95% CI: 23-58) for north, east, west, south, central, and northeast region-zones, respectively. The state-wise stratified results showed a predominance of MRSA in Jammu and Kashmir with 55% (95% CI: 42-67) prevalence, and the lowest was 21% (95% CI: 11-34) in Maharashtra. The study indicated that the prevalence data would help in formulating and strict implementation of control measures in hospital areas to prevent the outbreak of MRSA infection and management of antibiotic usage.

Keywords: Antimicrobial resistance; Humans; India; Meta-analysis; Methicillin-Resistant; Prevalence; Staphylococcus aureus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Systematic review and meta-analysis.
Figure 2
Figure 2
Heterogeneity assessment.
Figure 3
Figure 3
Zone analysis.
Figure 4
Figure 4
Galbraith plot assessment between study reports.

Similar articles

Cited by

References

    1. Ki V, Rotstein C. Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol 2008. Mar;19(2):173-184. 10.1155/2008/846453 - DOI - PMC - PubMed
    1. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015. Jul;28(3):603-661. 10.1128/CMR.00134-14 - DOI - PMC - PubMed
    1. Sasirekha B, Usha MS, Amruta AJ, Ankit S, Brinda N, Divya R. Evaluation and comparison of different phenotypic tests to detect methicillin resistant Staphylococcus aureus and their biofilm production. Int J Pharm Tech Res 2012;4(2):532-534.
    1. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T 2015. Apr;40(4):277-283. - PMC - PubMed
    1. Abbas A, Nirwan PS, Srivastava P. Prevalence and antibiogram of hospital acquired-methicillin resistant Staphylococcus aureus and community acquired-methicillin resistant Staphylococcus aureus at a tertiary care hospital National Institute of Medical Sciences. Communit Acquir Infect 2015;2(1):13 .10.4103/2225-6482.153857 - DOI

LinkOut - more resources